Table 3.
Multivariate Linear Regression, treated and untreated subgroups: TBS/BMD-L1–L4 as dependent variable.
| Predicting variable | TBS L1–L4: Unstandardized B coefficient ± Std. error; (p-value) | BMD L1–L4: Unstandardized B coefficient ± Std. error; (p-value) |
|---|---|---|
| Subgroup | −0.037 ± 0.034; (p = 0.278) | 0.011 ± 0.048 (p = 0.821) |
| Sex | 0.017 ± 0.022; (p = 0.430) | −0.055 ± 0.032 (p = 0.087) |
| Age, years | −0.002 ± 0.001; (p < 0.001⁎) | −0.001 ± 0.001 (p = 0.494) |
| BMI, kg/m2 | −0.005 ± 0.002; (p = 0.006⁎) | 0.013 ± 0.003 (p < 0.001⁎) |
| P-total calcium, mmol/l | −0.041 ± 0.065; (p = 0.525) | −0.024 ± 0.093 (p = 0.796) |
| P-PTH, pmol/l | −0.001 ± 0.001; (p = 0.391) | −0.003 ± 0.002 (p = 0.082) |
| P-Vitamin D (D2 + D3), nmol/l | −2.13 × 10−5 ± 0.000; (p = 0.948) | 0.000 ± 0.000 (p = 0.323) |
| P-Alkaline phosphatase, U/l | 0.000 ± 0.000; (p = 0.303) | −2.22 × 10−5 ± 0.000 (p = 0.954) |
| P-Creatinine, μmol/l | 0.000 ± 0.000; (p = 0.472) | 0.000 ± 0.001 (p = 0.664) |
| P-Phosphorous, mmol/l | −0.100 ± 0.055; (p = 0.071) | −0.062 ± 0.079 (p = 0.431) |
| Antiresorptive therapy | −0.030 ± 0.023; (p = 0.193) | −0.090 ± 0.033 (p < 0.01⁎) |
| Time from diagnosis | 0.000 ± 0.000; (p = 0.451) | 5.78 × 10−5 ± 0.000 (p = 0.794) |
| Model strength: R2 = 0.223 (n = 153) | Model strength: R2 = 0.241 (n = 147) |
⁎
p < 0.05.